(AROW) Arrow Financial - Ratings and Ratios
Deposits, Loans, Trust, Insurance, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.62% |
| Yield on Cost 5y | 4.95% |
| Yield CAGR 5y | 4.02% |
| Payout Consistency | 91.3% |
| Payout Ratio | 48.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Value at Risk 5%th | 48.5% |
| Relative Tail Risk | -7.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.45 |
| Alpha | 0.93 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.466 |
| Beta | 0.690 |
| Beta Downside | 0.712 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.52% |
| Mean DD | 20.61% |
| Median DD | 20.06% |
Description: AROW Arrow Financial December 27, 2025
Arrow Financial Corporation (NASDAQ:AROW) is a New York-based bank holding company that offers a full suite of commercial and consumer banking services across the United States, including demand and interest-bearing deposits, a broad array of loan products (commercial, CRE, consumer installment, auto, and residential), and ancillary wealth-management and insurance services.
Key operating metrics from the most recent quarter (Q3 2024) show a net interest margin of approximately 3.2%, a loan-to-deposit ratio of 73%, and a Common Equity Tier 1 (CET1) capital ratio of 12.5%, indicating solid liquidity and capital adequacy relative to regional-bank peers.
Sector-level drivers that materially affect Arrow’s performance are the Federal Reserve’s interest-rate policy (which sets the spread between loan yields and deposit costs) and the ongoing stress in commercial-real-estate (CRE) markets that can pressure loan-loss provisions for regional banks with sizable CRE exposure.
In Q3 2024 the company reported revenue of $140 million and earnings per share of $0.68, with a market capitalization near $1.2 billion; its balance sheet includes an indirect lending program that diversifies credit risk across third-party originators.
For a deeper quantitative dive, the ValueRay AROW dashboard provides granular historical data and scenario analytics that can help you assess the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (34.4m TTM) > 0 and > 6% of Revenue (6% = 14.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1354 % (prev -1393 %; Δ 39.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 41.0m > Net Income 34.4m (YES >=105%, WARN >=100%) |
| Net Debt (-368.2m) to EBITDA (49.3m) ratio: -7.46 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (16.4m) change vs 12m ago -2.01% (target <= -2.0% for YES) |
| Gross Margin 62.52% (prev 61.95%; Δ 0.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.22% (prev 4.98%; Δ 0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.56 (EBITDA TTM 49.3m / Interest Expense TTM 78.7m) >= 6 (WARN >= 3) |
Altman Z'' -4.39
| (A) -0.69 = (Total Current Assets 921.3m - Total Current Liabilities 4.10b) / Total Assets 4.59b |
| (B) 0.02 = Retained Earnings (Balance) 93.0m / Total Assets 4.59b |
| (C) 0.01 = EBIT TTM 43.8m / Avg Total Assets 4.50b |
| (D) 0.03 = Book Value of Equity 106.5m / Total Liabilities 4.17b |
| Total Rating: -4.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.79
| 1. Piotroski 4.0pt |
| 2. FCF Yield -9.55% |
| 3. FCF Margin 15.10% |
| 4. Debt/Equity 0.07 |
| 5. Debt/Ebitda -7.46 |
| 6. ROIC - WACC (= -0.32)% |
| 7. RoE 8.44% |
| 8. Rev. Trend 92.52% |
| 9. EPS Trend -28.85% |
What is the price of AROW shares?
Over the past week, the price has changed by -1.44%, over one month by +3.21%, over three months by +9.98% and over the past year by +13.12%.
Is AROW a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AROW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.5 | 6.5% |
| Analysts Target Price | 33.5 | 6.5% |
| ValueRay Target Price | 33.2 | 5.5% |
AROW Fundamental Data Overview December 27, 2025
P/E Trailing = 15.3544
P/S = 3.5481
P/B = 1.2451
P/EG = 2.41
Beta = 0.8
Revenue TTM = 234.8m USD
EBIT TTM = 43.8m USD
EBITDA TTM = 49.3m USD
Long Term Debt = 24.3m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 29.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -368.2m USD (from netDebt column, last quarter)
Enterprise Value = -371.2m USD (520.9m + Debt 29.2m - CCE 921.3m)
Interest Coverage Ratio = 0.56 (Ebit TTM 43.8m / Interest Expense TTM 78.7m)
FCF Yield = -9.55% (FCF TTM 35.5m / Enterprise Value -371.2m)
FCF Margin = 15.10% (FCF TTM 35.5m / Revenue TTM 234.8m)
Net Margin = 14.65% (Net Income TTM 34.4m / Revenue TTM 234.8m)
Gross Margin = 62.52% ((Revenue TTM 234.8m - Cost of Revenue TTM 88.0m) / Revenue TTM)
Gross Margin QoQ = 67.45% (prev 66.82%)
Tobins Q-Ratio = -0.08 (set to none) (Enterprise Value -371.2m / Total Assets 4.59b)
Interest Expense / Debt = 66.68% (Interest Expense 19.5m / Debt 29.2m)
Taxrate = 22.74% (3.77m / 16.6m)
NOPAT = 33.9m (EBIT 43.8m * (1 - 22.74%))
Current Ratio = 0.22 (Total Current Assets 921.3m / Total Current Liabilities 4.10b)
Debt / Equity = 0.07 (Debt 29.2m / totalStockholderEquity, last quarter 417.7m)
Debt / EBITDA = -7.46 (Net Debt -368.2m / EBITDA 49.3m)
Debt / FCF = -10.38 (Net Debt -368.2m / FCF TTM 35.5m)
Total Stockholder Equity = 407.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.75% (Net Income 34.4m / Total Assets 4.59b)
RoE = 8.44% (Net Income TTM 34.4m / Total Stockholder Equity 407.9m)
RoCE = 10.15% (EBIT 43.8m / Capital Employed (Equity 407.9m + L.T.Debt 24.3m))
RoIC = 7.78% (NOPAT 33.9m / Invested Capital 435.4m)
WACC = 8.11% (E(520.9m)/V(550.1m) * Re(8.56%) + (debt cost/tax rate unavailable))
Discount Rate = 8.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF Debug] Terminal Value 73.30% ; FCFE base≈24.4m ; Y1≈20.4m ; Y5≈15.1m
Fair Price DCF = 15.34 (DCF Value 252.3m / Shares Outstanding 16.4m; 5y FCF grow -19.99% → 3.0% )
EPS Correlation: -28.85 | EPS CAGR: 7.86% | SUE: 1.13 | # QB: 2
Revenue Correlation: 92.52 | Revenue CAGR: 15.80% | SUE: 0.89 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=+0.090 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.40 | Chg30d=+0.400 | Revisions Net=+1 | Growth EPS=+25.9% | Growth Revenue=+10.0%
Additional Sources for AROW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle